Literature DB >> 25598000

Tafazzins from Drosophila and mammalian cells assemble in large protein complexes with a short half-life.

Yang Xu1, Ashim Malhotra1, Steven M Claypool2, Mindong Ren1, Michael Schlame3.   

Abstract

Tafazzin is a transacylase that affects cardiolipin fatty acid composition and mitochondrial function. Mutations in human tafazzin cause Barth syndrome yet the enzyme has mostly been characterized in yeast. To study tafazzin in higher organisms, we isolated mitochondria from Drosophila and mammalian cell cultures. Our data indicate that tafazzin binds to multiple protein complexes in these organisms, and that the interactions of tafazzin lack strong specificity. Very large tafazzin complexes could only be detected in the presence of cardiolipin, but smaller complexes remained intact even upon treatment with phospholipase A2. In mammalian cells, tafazzin had a half-life of only 3-6h, which was much shorter than the half-life of other mitochondrial proteins. The data suggest that tafazzin is a transient resident of multiple protein complexes.
Copyright © 2015 © Elsevier B.V. and Mitochondria Research Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Barth syndrome; Cardiolipin; Membrane assembly; Mitochondria; Protein complex; Tafazzin

Mesh:

Substances:

Year:  2015        PMID: 25598000      PMCID: PMC4693151          DOI: 10.1016/j.mito.2015.01.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  34 in total

1.  Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.

Authors:  Zhiming Gu; Fredoen Valianpour; Shuliang Chen; Frederic M Vaz; Gertjan A Hakkaart; Ronald J A Wanders; Miriam L Greenberg
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

2.  The mitochondrial contact site complex, a determinant of mitochondrial architecture.

Authors:  Max Harner; Christian Körner; Dirk Walther; Dejana Mokranjac; Johannes Kaesmacher; Ulrich Welsch; Janice Griffith; Matthias Mann; Fulvio Reggiori; Walter Neupert
Journal:  EMBO J       Date:  2011-10-18       Impact factor: 11.598

3.  Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.

Authors:  Meghan S Soustek; Darin J Falk; Cathryn S Mah; Matthew J Toth; Michael Schlame; Alfred S Lewin; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

4.  Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis.

Authors:  Fredoen Valianpour; Voula Mitsakos; Dimitri Schlemmer; Jeffrey A Towbin; Juliet M Taylor; Paul G Ekert; David R Thorburn; Arnold Munnich; Ronald J A Wanders; Peter G Barth; Frédéric M Vaz
Journal:  J Lipid Res       Date:  2005-04-01       Impact factor: 5.922

5.  X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria.

Authors:  R I Kelley; J P Cheatham; B J Clark; M A Nigro; B R Powell; G W Sherwood; J T Sladky; W P Swisher
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

6.  Cardiac and clinical phenotype in Barth syndrome.

Authors:  Carolyn T Spencer; Randall M Bryant; Jane Day; Iris L Gonzalez; Steven D Colan; W Reid Thompson; Julie Berthy; Sharon P Redfearn; Barry J Byrne
Journal:  Pediatrics       Date:  2006-07-17       Impact factor: 7.124

7.  The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome.

Authors:  Steven M Claypool; Pinmanee Boontheung; J Michael McCaffery; Joseph A Loo; Carla M Koehler
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

8.  Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.

Authors:  Michael Schlame; Jeffrey A Towbin; Paul M Heerdt; Roswitha Jehle; Salvatore DiMauro; Thomas J J Blanck
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

9.  Aim24 and MICOS modulate respiratory function, tafazzin-related cardiolipin modification and mitochondrial architecture.

Authors:  Max Emanuel Harner; Ann-Katrin Unger; Toshiaki Izawa; Dirk M Walther; Cagakan Ozbalci; Stefan Geimer; Fulvio Reggiori; Britta Brügger; Matthias Mann; Benedikt Westermann; Walter Neupert
Journal:  Elife       Date:  2014-01-01       Impact factor: 8.140

10.  Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction.

Authors:  Colin K L Phoon; Devrim Acehan; Michael Schlame; David L Stokes; Irit Edelman-Novemsky; Dawen Yu; Yang Xu; Nitya Viswanathan; Mindong Ren
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

View more
  7 in total

Review 1.  TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

Authors:  Anders O Garlid; Calvin T Schaffer; Jaewoo Kim; Hirsh Bhatt; Vladimir Guevara-Gonzalez; Peipei Ping
Journal:  Gene       Date:  2019-10-21       Impact factor: 3.688

Review 2.  Biosynthesis, remodeling and turnover of mitochondrial cardiolipin.

Authors:  Michael Schlame; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-08-21       Impact factor: 4.698

3.  A novel mutation in TAZ causes mitochondrial respiratory chain disorder without cardiomyopathy.

Authors:  Nurun N Borna; Yoshihito Kishita; Kaori Ishikawa; Kazuto Nakada; Jun-Ichi Hayashi; Yoshimi Tokuzawa; Masakazu Kohda; Hiromi Nyuzuki; Yzumi Yamashita-Sugahara; Takashi Nasu; Atsuhito Takeda; Kei Murayama; Akira Ohtake; Yasushi Okazaki
Journal:  J Hum Genet       Date:  2017-01-26       Impact factor: 3.172

Review 4.  Barth Syndrome Cardiomyopathy: An Update.

Authors:  Jing Pang; Yutong Bao; Kalia Mitchell-Silbaugh; Jennifer Veevers; Xi Fang
Journal:  Genes (Basel)       Date:  2022-04-08       Impact factor: 4.141

Review 5.  The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.

Authors:  Michael Schlame; Yang Xu
Journal:  J Mol Biol       Date:  2020-03-29       Impact factor: 5.469

Review 6.  Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies.

Authors:  Ana Saric; Karine Andreau; Anne-Sophie Armand; Ian M Møller; Patrice X Petit
Journal:  Front Genet       Date:  2016-01-20       Impact factor: 4.599

Review 7.  Cardiolipin, the Mitochondrial Signature Lipid: Implication in Cancer.

Authors:  Seyedeh Tayebeh Ahmadpour; Karine Mahéo; Stéphane Servais; Lucie Brisson; Jean-François Dumas
Journal:  Int J Mol Sci       Date:  2020-10-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.